Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$8,720,584
+$1,310,918 QoQ
Shares Held
34,655
+1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#992
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Koshinski Asset Management, Inc. holds $47,150,309 across 10 Drug Manufacturers - General names. ABBV ranks #2 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,147 | $21,370,813 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
34,655 | $8,720,584 | |
| 3 | LLY |
ELI LILLY & Co
|
5,099 | $6,115,894 | |
| 4 | PFE |
Pfizer Inc
|
146,261 | $3,521,964 | |
| 5 | AMGN |
Amgen Inc
|
9,577 | $3,468,023 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,669 | $1,248,567 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,983 | $1,008,572 | |
| 8 | AZN |
Astrazeneca PLC
|
4,741 | $898,988 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,720,584 | 34,655 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $7,409,666 | 34,069 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $7,766,146 | 33,989 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $7,923,530 | 34,221 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,130,657 | 33,028 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $7,020,805 | 33,509 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $5,829,448 | 32,805 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $6,567,987 | 33,259 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $5,882,964 | 34,299 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $6,140,412 | 33,720 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,569,289 | 29,485 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $5,202,194 | 34,900 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $4,709,891 | 34,958 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $7,263,447 | 45,576 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $7,451,998 | 46,111 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $6,143,060 | 45,772 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $6,987,925 | 45,625 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $10,478,141 | 64,636 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $8,812,238 | 65,083 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $6,900,336 | 63,969 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $5,885,665 | 52,252 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $7,541,202 | 69,684 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $13,235,382 | 123,522 | Shares | Sole | 2021-03-30 | |
| 2020-09-30 | $5,118,584 | 58,438 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,893,058 | 60,023 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $4,274,792 | 56,107 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||